News Releases

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Email Alerts

Year All Years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go

Advanced Search

Keywords

  Search Headlines Only

From

To

Asset Types

 Photos  Video  Audio  Documents  Events  Standard

 Basic Search

• Dec 15, 2014

  Insmed Appoints Myrtle Potter to its Board of Directors

  Pharmaceutical executive brings 30 years of commercial and operations leadership
• Nov 26, 2014

  Insmed to Participate at December Investment Conferences
• Nov 6, 2014

  Insmed Reports Third Quarter 2014 Financial Results

  Conference Call Begins Today at 8:30 a.m. Eastern Time
• Sep 24, 2014

  Insmed to Participate in Leerink Partners' Rare Disease Roundtable
• Sep 3, 2014

  Insmed Announces Multiple Clinical and Scientific Presentations at European Respiratory Society's International Congress 2014
• Aug 18, 2014

  Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares
• Aug 12, 2014

  Insmed Announces Pricing of Public Offering of Common Stock
• Aug 6, 2014

  Insmed Reports Second Quarter 2014 Financial Results
• Aug 4, 2014

  Insmed Provides Regulatory Update for ARIKAYCE

  Filing Marketing Authorization Application with European Medicines Agency for NTM Lung Disease and CF Indications
• Jun 20, 2014

  Insmed to Present at the JMP Securities Healthcare Conference

Show 5102550100 per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

Sign Up

View the latest Insmed Investor Presentation

Download